A Study to Evaluate Safety, Tolerability, and Immunogenicity of an Investigational Zoster Vaccine In Subjects With a History of Varicella (Chickenpox)(V211-010)(COMPLETED)
Condition: Herpes ZosterInterventions: Biological: Comparator: zoster vaccine live (Oka/Merck) refrigerated formulation; Biological: Comparator: zoster vaccine live (Oka/Merck) frozen formulationSponsor: Merck Sharp & Dohme Corp.Completed - verified January 2015
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials